{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:14:17Z","timestamp":1790810057932,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bone marrow stromal antigen 2 (BST-2) mediates various facets of cancer progression and metastasis. Here, we show that BST-2 is linked to poor survival in invasive breast cancer patients as its expression positively correlates with disease severity. However, the mechanisms that drive the pro\u2010metastatic functions of BST-2 are not fully understood. Correlation of BST-2 expression and tumor aggressiveness was analyzed in human tissue samples. Migration, invasion, and competitive experimental metastasis assays were used to measure the cellular responses after silencing BST-2 expression. Using a mouse model of breast cancer, we show that BST-2 promotes metastasis independent of the primary tumor. Additional experiments show that suppression of BST-2 renders non-adherent cancer cells non-viable by sensitizing cells to anoikis. Embedment of cancer cells in basement membrane matrix reveals that silencing BTS-2 expression inhibits invadopodia formation, extracellular matrix degradation, and subsequent cell invasion. Competitive experimental pulmonary metastasis shows that silencing BST-2 reduces the numbers of viable circulating tumor cells (CTCs) and decreases the efficiency of lung colonization. Our data define a previously unknown function for BST-2 in the i) formation of invadopodia, ii) degradation of extracellular matrix, and iii) protection of CTCs from hemodynamic stress. We believe that physical (tractional forces) and biochemical (ECM type\/composition) cues may control BST-2\u2019s role in cell survival and invadopodia formation. Collectively, our findings highlight BST-2 as a key factor that allows cancer cells to invade, survive in circulation, and at the metastatic site.<\/jats:p>","DOI":"10.1038\/s41598-018-35710-y","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T17:55:22Z","timestamp":1543427722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["BST-2 promotes survival in circulation and pulmonary metastatic seeding of breast cancer cells"],"prefix":"10.1038","volume":"8","author":[{"given":"Wadie D.","family":"Mahauad-Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasifa","family":"Naushad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler D.","family":"Panzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chioma M.","family":"Okeoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"35710_CR1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537\u201349 (2003).","journal-title":"Cancer Cell"},{"key":"35710_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","volume":"133","author":"D Padua","year":"2008","unstructured":"Padua, D. et al. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133, 66\u201377 (2008).","journal-title":"Cell"},{"key":"35710_CR3","doi-asserted-by":"publisher","first-page":"e0123931","DOI":"10.1371\/journal.pone.0123931","volume":"10","author":"WD Mahauad-Fernandez","year":"2015","unstructured":"Mahauad-Fernandez, W. D., Borcherding, N. C., Zhang, W. & Okeoma, C. M. Bone marrow stromal antigen 2 (BST-2) DNA is demethylated in breast tumors and breast cancer cells. PLoS One 10, e0123931 (2015).","journal-title":"PLoS One"},{"key":"35710_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-014-0493-8","volume":"16","author":"WD Mahauad-Fernandez","year":"2014","unstructured":"Mahauad-Fernandez, W. D., DeMali, K. A., Olivier, A. K. & Okeoma, C. M. Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis. Breast Cancer Res 16, 493 (2014).","journal-title":"Breast Cancer Res"},{"key":"35710_CR5","doi-asserted-by":"crossref","unstructured":"Mahauad-Fernandez, W.D. & Okeoma, C.M. The role of BST-2\/Tetherin in host protection and disease manifestation. Immunity, Inflammation and Disease (2015).","DOI":"10.1002\/iid3.92"},{"key":"35710_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2217\/fvl.15.113","volume":"11","author":"WD Mahauad-Fernandez","year":"2016","unstructured":"Mahauad-Fernandez, W. D. & Okeoma, C. M. BST-2: at the crossroads of viral pathogenesis and oncogenesis. Future Virology 11, 127\u2013140 (2016).","journal-title":"Future Virology"},{"issue":"3","key":"35710_CR7","doi-asserted-by":"publisher","first-page":"e2687","DOI":"10.1038\/cddis.2017.68","volume":"8","author":"Wadie D Mahauad-Fernandez","year":"2017","unstructured":"Mahauad-Fernandez, W. D. & Okeoma, C. M. Cysteine-linked dimerization of BST-2 confers anoikis resistance to breast cancer cells by negating proapoptotic activities to promote tumor cell survival and growth. Cell death and disease 8, (2017).","journal-title":"Cell Death & Disease"},{"key":"35710_CR8","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1245\/s10434-016-5100-z","volume":"24","author":"S Mukai","year":"2017","unstructured":"Mukai, S. et al. Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer. Ann Surg Oncol 24, 594\u2013602 (2017).","journal-title":"Ann Surg Oncol"},{"key":"35710_CR9","doi-asserted-by":"publisher","first-page":"965384","DOI":"10.1155\/2014\/965384","volume":"2014","author":"T Harada","year":"2014","unstructured":"Harada, T. & Ozaki, S. Targeted therapy for HM1.24 (CD317) on multiple myeloma cells. Biomed Res Int 2014, 965384 (2014).","journal-title":"Biomed Res Int"},{"key":"35710_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.bbrc.2013.05.043","volume":"435","author":"EH Yi","year":"2013","unstructured":"Yi, E. H. et al. BST-2 is a potential activator of invasion and migration in tamoxifen-resistant breast cancer cells. Biochem Biophys Res Commun 435, 685\u201390 (2013).","journal-title":"Biochem Biophys Res Commun"},{"key":"35710_CR11","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3892\/ol.2017.6230","volume":"14","author":"Y Shigematsu","year":"2017","unstructured":"Shigematsu, Y. et al. Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer. Oncol Lett 14, 999\u20131004 (2017).","journal-title":"Oncol Lett"},{"key":"35710_CR12","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood.V84.6.1922.1922","volume":"84","author":"T Goto","year":"1994","unstructured":"Goto, T. et al. A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood 84, 1922\u201330 (1994).","journal-title":"Blood"},{"key":"35710_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature06553","volume":"451","author":"SJ Neil","year":"2008","unstructured":"Neil, S. J., Zang, T. & Bieniasz, P. D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425\u201330 (2008).","journal-title":"Nature"},{"key":"35710_CR14","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1089\/aid.2009.0253","volume":"25","author":"A Tokarev","year":"2009","unstructured":"Tokarev, A., Skasko, M., Fitzpatrick, K. & Guatelli, J. Antiviral activity of the interferon-induced cellular protein BST-2\/tetherin. AIDS Res Hum Retroviruses 25, 1197\u2013210 (2009).","journal-title":"AIDS Res Hum Retroviruses"},{"key":"35710_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.virol.2013.01.010","volume":"438","author":"PH Jones","year":"2013","unstructured":"Jones, P. H. et al. BST-2\/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1). Virology 438, 37\u201349 (2013).","journal-title":"Virology"},{"key":"35710_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1042\/BCJ20160861","volume":"474","author":"S Hu","year":"2017","unstructured":"Hu, S. et al. BST-2 restricts IAV release and is countered by the viral M2 protein. Biochem J 474, 715\u2013730 (2017).","journal-title":"Biochem J"},{"key":"35710_CR17","doi-asserted-by":"crossref","unstructured":"Kmiec, D. et al. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance. MBio 7 (2016).","DOI":"10.1128\/mBio.00934-16"},{"key":"35710_CR18","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1128\/JVI.07062-11","volume":"86","author":"K Sato","year":"2012","unstructured":"Sato, K. et al. Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice. J Virol 86, 5000\u201313 (2012).","journal-title":"J Virol"},{"key":"35710_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-9-10","volume":"9","author":"PH Jones","year":"2012","unstructured":"Jones, P. H., Mehta, H. V., Maric, M., Roller, R. J. & Okeoma, C. M. Bone marrow stromal cell antigen 2 (BST-2) restricts mouse mammary tumor virus (MMTV) replication in vivo. Retrovirology 9, 10 (2012).","journal-title":"Retrovirology"},{"key":"35710_CR20","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1099\/vir.0.068643-0","volume":"95","author":"WD Mahauad-Fernandez","year":"2014","unstructured":"Mahauad-Fernandez, W. D., Jones, P. H. & Okeoma, C. M. Critical role for bone marrow stromal antigen 2 in acute Chikungunya virus infection. J Gen Virol 95, 2450\u201361 (2014).","journal-title":"J Gen Virol"},{"key":"35710_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep20425","volume":"6","author":"SX Li","year":"2016","unstructured":"Li, S. X. et al. Tetherin\/BST-2 promotes dendritic cell activation and function during acute retrovirus infection. Sci Rep 6, 20425 (2016).","journal-title":"Sci Rep"},{"key":"35710_CR22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4049\/jimmunol.1400490","volume":"193","author":"SX Li","year":"2014","unstructured":"Li, S. X. et al. Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo. J Immunol 193, 306\u201316 (2014).","journal-title":"J Immunol"},{"key":"35710_CR23","doi-asserted-by":"crossref","unstructured":"Jones, P. H. & Okeoma, C. M. Phosphatidylinositol 3- kinase is involved in Toll-like receptor 4-mediated BST-2\/Tetherin regulation. Cell Signal (2013).","DOI":"10.1016\/j.cellsig.2013.08.042"},{"key":"35710_CR24","doi-asserted-by":"crossref","unstructured":"Richard, J. et al. BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity. J Virol 91 (2017).","DOI":"10.1128\/JVI.00219-17"},{"key":"35710_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jaut.2013.04.003","volume":"43","author":"P Coit","year":"2013","unstructured":"Coit, P. et al. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. J Autoimmun 43, 78\u201384 (2013).","journal-title":"J Autoimmun"},{"key":"35710_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.4161\/epi.6.5.15374","volume":"6","author":"MA Jeffries","year":"2011","unstructured":"Jeffries, M. A. et al. Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus. Epigenetics 6, 593\u2013601 (2011).","journal-title":"Epigenetics"},{"key":"35710_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.virol.2013.05.042","volume":"444","author":"PH Jones","year":"2013","unstructured":"Jones, P. H., Mahauad-Fernandez, W. D., Madison, M. N. & Okeoma, C. M. BST-2\/tetherin is overexpressed in mammary gland and tumor tissues in MMTV-induced mammary cancer. Virology 444, 124\u201339 (2013).","journal-title":"Virology"},{"key":"35710_CR28","doi-asserted-by":"publisher","first-page":"110221","DOI":"10.18632\/oncotarget.22753","volume":"8","author":"W Naushad","year":"2017","unstructured":"Naushad, W., Mahauad-Fernandez, W. D. & Okeoma, C. M. Structural determinant of BST-2-mediated regulation of breast cancer cell motility: a role for cytoplasmic tail tyrosine residues. Oncotarget 8, 110221\u2013110233 (2017).","journal-title":"Oncotarget"},{"key":"35710_CR29","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1245\/s10434-009-0533-2","volume":"16","author":"G Lal","year":"2009","unstructured":"Lal, G. et al. Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: a Hospital-based Cohort Study in Iowa. Ann Surg Oncol 16, 2280\u20137 (2009).","journal-title":"Ann Surg Oncol"},{"key":"35710_CR30","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1242\/jcs.052704","volume":"122","author":"C Albiges-Rizo","year":"2009","unstructured":"Albiges-Rizo, C., Destaing, O., Fourcade, B., Planus, E. & Block, M. R. Actin machinery and mechanosensitivity in invadopodia, podosomes and focal adhesions. J Cell Sci 122, 3037\u201349 (2009).","journal-title":"J Cell Sci"},{"key":"35710_CR31","doi-asserted-by":"crossref","unstructured":"Martin, K. H. et al. Quantitative measurement of invadopodia-mediated extracellular matrix proteolysis in single and multicellular contexts. J Vis Exp, e4119 (2012).","DOI":"10.3791\/4119"},{"key":"35710_CR32","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.celrep.2014.07.050","volume":"8","author":"HS Leong","year":"2014","unstructured":"Leong, H. S. et al. Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis. Cell Rep 8, 1558\u201370 (2014).","journal-title":"Cell Rep"},{"key":"35710_CR33","first-page":"2125","volume":"62","author":"Y Hegerfeldt","year":"2002","unstructured":"Hegerfeldt, Y., Tusch, M., Brocker, E. B. & Friedl, P. Collective cell movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-integrin function, and migration strategies. Cancer Res 62, 2125\u201330 (2002).","journal-title":"Cancer Res"},{"key":"35710_CR34","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871\u201390 (2009).","journal-title":"Cell"},{"key":"35710_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1083\/jcb.200209006","volume":"160","author":"K Wolf","year":"2003","unstructured":"Wolf, K. et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160, 267\u201377 (2003).","journal-title":"J Cell Biol"},{"issue":"6","key":"35710_CR36","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3390\/ijms17060818","volume":"17","author":"Long Fan","year":"2016","unstructured":"Fan, L. et al. MT1-MMP Inhibits the Activity of Bst-2 via Their Cytoplasmic Domains Dependent Interaction. Int J Mol Sci 17 (2016).","journal-title":"International Journal of Molecular Sciences"},{"key":"35710_CR37","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/jcb.23433","volume":"113","author":"G Gu","year":"2012","unstructured":"Gu, G., Zhao, D., Yin, Z. & Liu, P. BST-2 binding with cellular MT1-MMP blocks cell growth and migration via decreasing MMP2 activity. J Cell Biochem 113, 1013\u201321 (2012).","journal-title":"J Cell Biochem"},{"key":"35710_CR38","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1111\/cas.12738","volume":"106","author":"K Hiramatsu","year":"2015","unstructured":"Hiramatsu, K. et al. CpG oligodeoxynucleotides potentiate the antitumor activity of anti-BST2 antibody. Cancer Sci 106, 1474\u20138 (2015).","journal-title":"Cancer Sci"},{"key":"35710_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3892\/ijo.2016.3521","volume":"49","author":"N Woodman","year":"2016","unstructured":"Woodman, N. et al. Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer. Int J Oncol 49, 265\u201375 (2016).","journal-title":"Int J Oncol"},{"key":"35710_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.271","volume":"8","author":"CM Kuang","year":"2017","unstructured":"Kuang, C. M. et al. BST2 confers cisplatin resistance via NF-kappaB signaling in nasopharyngeal cancer. Cell Death Dis 8, e2874 (2017).","journal-title":"Cell Death Dis"},{"key":"35710_CR41","doi-asserted-by":"crossref","unstructured":"Hoshino, D. et al. Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCalpha invasive signaling axis. Sci Signal 5, ra66 (2012).","DOI":"10.1126\/scisignal.2002964"},{"key":"35710_CR42","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1083\/jcb.200909113","volume":"189","author":"M Schoumacher","year":"2010","unstructured":"Schoumacher, M., Goldman, R. D., Louvard, D. & Vignjevic, D. M. Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia. J Cell Biol 189, 541\u201356 (2010).","journal-title":"J Cell Biol"},{"key":"35710_CR43","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/nmeth.1269","volume":"5","author":"D Kedrin","year":"2008","unstructured":"Kedrin, D. et al. Intravital imaging of metastatic behavior through a mammary imaging window. Nat Methods 5, 1019\u201321 (2008).","journal-title":"Nat Methods"},{"key":"35710_CR44","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1038\/onc.2013.377","volume":"33","author":"M Roh-Johnson","year":"2014","unstructured":"Roh-Johnson, M. et al. Macrophage contact induces RhoA GTPase signaling to trigger tumor cell intravasation. Oncogene 33, 4203\u201312 (2014).","journal-title":"Oncogene"},{"key":"35710_CR45","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ccr.2011.01.036","volume":"19","author":"MA Eckert","year":"2011","unstructured":"Eckert, M. A. et al. Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 19, 372\u201386 (2011).","journal-title":"Cancer Cell"},{"key":"35710_CR46","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1242\/jcs.092726","volume":"125","author":"B Gligorijevic","year":"2012","unstructured":"Gligorijevic, B. et al. N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J Cell Sci 125, 724\u201334 (2012).","journal-title":"J Cell Sci"},{"key":"35710_CR47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-3-319-42023-3_5","volume":"936","author":"KA Rejniak","year":"2016","unstructured":"Rejniak, K. A. Circulating Tumor Cells: When a Solid Tumor Meets a Fluid Microenvironment. Adv Exp Med Biol 936, 93\u2013106 (2016).","journal-title":"Adv Exp Med Biol"},{"key":"35710_CR48","first-page":"773","volume":"45","author":"IJ Fidler","year":"1970","unstructured":"Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2\u2032-deoxyuridine. J Natl Cancer Inst 45, 773\u201382 (1970).","journal-title":"J Natl Cancer Inst"},{"key":"35710_CR49","doi-asserted-by":"publisher","first-page":"e50973","DOI":"10.1371\/journal.pone.0050973","volume":"7","author":"JM Barnes","year":"2012","unstructured":"Barnes, J. M., Nauseef, J. T. & Henry, M. D. Resistance to fluid shear stress is a conserved biophysical property of malignant cells. PLoS One 7, e50973 (2012).","journal-title":"PLoS One"},{"key":"35710_CR50","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto, N. et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110\u201322 (2014).","journal-title":"Cell"},{"key":"35710_CR51","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/bjc.2013.768","volume":"110","author":"Y Yu","year":"2014","unstructured":"Yu, Y. et al. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-beta signalling. Br J Cancer 110, 724\u201332 (2014).","journal-title":"Br J Cancer"},{"key":"35710_CR52","first-page":"450","volume":"27","author":"XL Lou","year":"2015","unstructured":"Lou, X. L. et al. Interaction between circulating cancer cells and platelets: clinical implication. Chin J Cancer Res 27, 450\u201360 (2015).","journal-title":"Chin J Cancer Res"},{"key":"35710_CR53","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.3892\/ijo.2016.3747","volume":"49","author":"Y Hong","year":"2016","unstructured":"Hong, Y., Fang, F. & Zhang, Q. Circulating tumor cell clusters: What we know and what we expect (Review). Int J Oncol 49, 2206\u20132216 (2016).","journal-title":"Int J Oncol"},{"key":"35710_CR54","first-page":"109","volume":"2","author":"G Barriere","year":"2014","unstructured":"Barriere, G. et al. Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations. Ann Transl Med 2, 109 (2014).","journal-title":"Ann Transl Med"},{"key":"35710_CR55","first-page":"2779","volume":"14","author":"P Ferroni","year":"1994","unstructured":"Ferroni, P., Roselli, M., Diodati, A., Casciani, C. U. & Gazzaniga, P. P. Effects on platelet function by human interferon-beta in carcinoma patients. Anticancer Res 14, 2779\u201384 (1994).","journal-title":"Anticancer Res"},{"key":"35710_CR56","doi-asserted-by":"crossref","unstructured":"Cvetkovic, D., Goertzen, C. G. & Bhattacharya, M. Quantification of breast cancer cell invasiveness using a three-dimensional (3D) model. J Vis Exp (2014).","DOI":"10.3791\/51341"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35710-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35710-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35710-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T12:06:10Z","timestamp":1671624370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35710-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,4]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["35710"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-35710-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,4]]},"assertion":[{"value":"12 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17608"}}